Designing and comparative analysis of anti-oxidant and heat shock proteins based multi-epitopic filarial vaccines.
Autor: | Kumar S; Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, UP, 221005, India., Mishra A; Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, UP, 221005, India., Kumar V; Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, UP, 221005, India., Singh T; Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, UP, 221005, India., Singh AK; Department of Medical Health and Family Welfare, Malaria and Vector Borne Disease, Filaria Control Unit Varanasi, Varanasi, UP, 221005, India., Singh A; Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, UP, 221005, India. anchalsinghbhu@yahoo.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | BMC infectious diseases [BMC Infect Dis] 2024 Dec 18; Vol. 24 (1), pp. 1436. Date of Electronic Publication: 2024 Dec 18. |
DOI: | 10.1186/s12879-024-10272-9 |
Abstrakt: | Background: Lymphatic Filariasis (LF) is a neglected tropical disease affecting more than 882 million people in 44 countries of the world. A multi-epitope prophylactic/therapeutic vaccination targeting filarial defense proteins would be invaluable to achieve the current LF elimination goal. Method: Two groups of proteins, namely Anti-oxidant (AO) and Heat shock proteins (HSPs), have been implicated in the effective survival of the filarial parasites in their hosts. Several B-cell, CTL, and T-helper epitopes were predicted from the three anti-oxidant proteins GST, GPx, and SOD. Likewise, epitopes were also predicted for HSP110, HSP90, and HSP70. Among the predicted epitopes, screening was applied to include only non-allergenic, non-toxic epitopes to construct two MEVs, PV Results: Conservation of the selected AOs and HSPs in other parasitic nematode species suggested that both the generated chimera could be helpful in cross-protection too. The 3D models of both MEVs contained more than 97% residues in allowed regions, as predicted by PROCHECK server. High MMGBSA and docking scores were obtained between MEVs and TLR4, TLR1/2, TLR6, and TLR9. Molecular dynamics simulation confirmed the stability of candidate vaccines in dynamic conditions present in the biological systems. The in-silico immune simulation indicated significantly high levels of IgG Conclusion: The immunoinformatics approaches used in this study confirmed that, the designed vaccines are capable of eliciting sustained immunity against LF, however, additional in-vivo studies would be required to confirm their efficacy. Furthermore, by employing multi-epitope structures and constructing two different cocktail vaccines for LF, this study can form an important milestone in the development of future LF vaccine/s. Competing Interests: Declarations. Ethical approval: This study does not involve any human or animal subject. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests. (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |